Q3 2022 Holdings
Filed 2022-11-08 | 66 holdings | $40.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $12.1M | 45,500 | 29.7% |
| Alnylam Pharms.(ALNY) | COM | 02043Q107 | $7.6M | 38,000 | 18.6% |
| Biomarin Pharm.(BMRN) | COM | 09061G101 | $5.0M | 58,656 | 12.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $4.3M | 573,530 | 10.5% |
| Ascendis Pharma ADR(ASND) | Sponsored ADR | 04351P101 | $3.0M | 29,400 | 7.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $2.7M | 257,892 | 6.6% |
| Beigene ADR(ONC) | Sponsored ADR | 07725L102 | $2.1M | 15,700 | 5.2% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $1.1M | 23,500 | 2.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $756.0K | 17,000 | 1.8% |
| Biocryst Pharms.(BCRX) | COM | 09058V103 | $718.0K | 57,000 | 1.8% |
| Axsome Therapeutics(AXSM) | COM | 05464T104 | $625.0K | 14,000 | 1.5% |
| Allogene Therapeutics(ALLO) | COM | 019770106 | $539.0K | 50,000 | 1.3% |
| Horizon Therapeutics | SHS | G4617B105 | $28.2K | 454,973 | 0.1% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $22.7K | 166,200 | 0.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $19.3K | 289,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $13.2K | 593,000 | 0.0% |
| Gilead Sciences(GILD) | COM | 375558103 | $12.9K | 208,784 | 0.0% |
| Harmony Biosciences Hldgs(HRMY) | COM | 413197104 | $11.7K | 264,500 | 0.0% |
| Intra-Cellular Therapies(ITCIEUR) | COM | 46116X101 | $10.3K | 221,856 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.2K | 544,500 | 0.0% |
| Supernus Pharms.(SUPN) | COM | 868459108 | $10.1K | 297,500 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $9.5K | 136,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $8.5K | 543,000 | 0.0% |
| Regeneron Pharms.(REGN) | COM | 75886F107 | $7.7K | 11,200 | 0.0% |
| Ultragenyx Pharm.(RARE) | COM | 90400D108 | $7.2K | 174,052 | 0.0% |
| Chinook Therapeutics(290A) | COM | 16961L106 | $6.7K | 340,389 | 0.0% |
| Vera Therapeutics(VERA) | CL A | 92337R101 | $6.0K | 281,257 | 0.0% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $5.5K | 143,500 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $5.3K | 123,300 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $4.8K | 25,000 | 0.0% |
| Kalvista Pharms.(KALV) | COM | 483497103 | $4.6K | 316,133 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $4.6K | 186,019 | 0.0% |
| Dyne Therapeutics(DYN) | COM | 26818M108 | $4.4K | 350,068 | 0.0% |
| Guardant Health(GH) | COM | 40131M109 | $4.0K | 74,500 | 0.0% |
| Amgen Inc COM(AMGN) | COM | 031162100 | $3.7K | 16,246 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.2K | 120,000 | 0.0% |
| Neurocrine Biosciences(NBIX) | COM | 64125C109 | $3.2K | 30,000 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.1K | 15,000 | 0.0% |
| Krystal Biotech(KRYS) | COM | 501147102 | $3.1K | 45,000 | 0.0% |
| United Therapeutics Corp del(VTRS) | COM | 92556V106 | $3.1K | 364,000 | 0.0% |
| Fate Therapeutics(FATE) | COM | 31189P102 | $2.7K | 121,000 | 0.0% |
| Zai Lab Ltd ADR (V1 Ord)(ZLAB) | ADR | 98887Q104 | $2.7K | 78,958 | 0.0% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $2.4K | 32,000 | 0.0% |
| Novavax Inc(NVAX) | COM | 670002401 | $2.4K | 132,500 | 0.0% |
| Jazz Pharms.(JAZZ) | SHS USD | G50871105 | $2.3K | 17,200 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.2K | 34,200 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $2.2K | 154,708 | 0.0% |
| I-Mab(NBP) | SPONSORED ADS | 44975P103 | $2.0K | 507,239 | 0.0% |
| Ideaya Biosciences(IDYA) | COM | 45166A102 | $1.6K | 109,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $1.6K | 193,741 | 0.0% |